ProNAi Therapeutics CEO Nick Glover's 2019 pay slips 1% to $1.9M
ProNAi Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
ProNAi Therapeutics reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, three executives at ProNAi Therapeutics received on average a compensation package of $1.3M, which is about the same as previous year.
Average pay of disclosed executives at ProNAi Therapeutics
Nick Glover, Chief Executive Officer, received $1.9M in total, which decreased by 1% compared to 2018. 47% of Glover's compensation, or $904K, was in option awards. Glover also received $346K in non-equity incentive plan, $608K in salary, as well as $60K in other compensation.
Barbara Klencke, Chief Development Officer, received a compensation package of $971K, which is about the same as previous year. 50% of the compensation package, or $486K, was in salary.
Mark Kowalski, Chief Medical Officer, earned $898K in 2019.
Related executives
You may also like
Source: SEC filing on April 24, 2020.